Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B

PHASE4CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

September 2, 2019

Study Completion Date

August 28, 2020

Conditions
PrematurityVaccinationMeningococcal Disease
Interventions
BIOLOGICAL

4CMenB Vaccine

The infants will receive an intramuscular injection of the 4CMenB vaccine at 2 months

BIOLOGICAL

4CMenB Vaccine

The infants will receive an intramuscular injection of the 4CMenB vaccine at 3 months

BIOLOGICAL

4CMenB Vaccine

The infants will receive an intramuscular injection of the 4CMenB vaccine at 4 months

BIOLOGICAL

4CMenB Vaccine

The infants will receive an intramuscular injection of the 4CMenB vaccine at 12 months

Trial Locations (1)

SW17 0QT

St Georges University Hospital NHS Foundation Trust, Tooting

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

MeningitisNow

UNKNOWN

collaborator

Public Health England

OTHER_GOV

lead

St George's, University of London

OTHER

NCT03125616 - Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B | Biotech Hunter | Biotech Hunter